Read news on cancer immunotherapy with our app.
Read more in the app
Boosted 'Natural Killer' Cells Could Lead to Off-The-Shelf Cancer Immunotherapy
Leveraging the power of T cells: Oxford team maps the future of cancer immunotherapy - EurekAlert!
Scientists just cracked the mystery of why cancer immunotherapy fails
Why cancer immunotherapy fails: Ohio State researchers link it to protein quality control collapse - EurekAlert!
Resolving the structural basis of therapeutic antibody function in cancer immunotherapy - EurekAlert!
Unlocking NK cells: Novel checkpoint targets revolutionize cancer immunotherapy - EurekAlert!
Challenging over 150 years of cancer immunotherapy: AUN bacteria herald an immune-independent breakthrough - EurekAlert!
Cancer immunotherapy linked to rare liver complication, study warns - EurekAlert!
Gut microbiome transplants show promise for boosting cancer immunotherapy - EurekAlert!
Powering up T cells: a new path in cancer immunotherapy - EurekAlert!
Giving T cells a break: controlled physical barrier created to boost cancer immunotherapy - EurekAlert!
Cancer immunotherapy shows promise for transplant patients - EurekAlert!
Researchers uncover surprising role of 'natural killer' cells in resistance to cancer immunotherapy - EurekAlert!
Cancer immunotherapy could get cheaper, more widely available with new technology - EurekAlert!
New immune boost could expand access to cancer immunotherapy
Moffitt study shows new immune boost could expand access to cancer immunotherapy - EurekAlert!
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy - EurekAlert!
Rare side effect of cancer immunotherapy
Rice bioengineers shed light on dosing challenges for cancer immunotherapy - EurekAlert
Bioengineers shed light on dosing challenges for cancer immunotherapy